Greater Glasgow and Clyde Medicines
Key to symbols The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP The medicine should only be used and prescribed by a specialist Indicates the preferred choice within a class or group of medicines
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
5. Infections

5.6. COVID-19 infection

Total Formulary
MOLNUPIRAVIR (LAGEVRIO)

Restrictions:

For treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults with a positive SARS-COV-2 diagnostic test only if:

  • they have 1 or more risk factors for progression to severe COVID-19 (as defined in section 5 of
    NICE’s technology appraisal guidance on nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for
    treating COVID-19) and
  • both nirmatrelvir plus ritonavir and sotrovimab are contraindicated or unsuitable.

For use in accordance with current NHSGGC prescribing guidance for COVID-19 (see here for a brief overview of the therapeutic management of each patient group).

Prescribing Notes:

Supply in primary care is via HSCP Pharmacists.

BNF Link

NIRMATRELVIR, RITONAVIR (PAXLOVID)

Restrictions:

Restricted to use in patients with increased risk for progression to severe COVID-19 in accordance with current NHSGGC prescribing guidance for COVID-19 (see here for a brief overview of the therapeutic management of each patient group).

Prescribing Notes:

Supply in primary care is via HSCP Pharmacists.

BNF Link

Specialist Only
REMDESIVIR (VEKLURY) (Infusion)

Restrictions:

For treatment of COVID-19 patients in hospital, only if they have a high risk of serious illness. For use in accordance with current NHSGGC prescribing guidance for COVID-19 (see here for a brief overview of the therapeutic management of each patient group).

BNF Link

Specialist Only
SOTROVIMAB (Xevudy)

Restrictions:

Restricted to use in accordance with current NHSGGC prescribing guidance for COVID-19 (see here for a brief overview of the therapeutic management of each patient group) for patients with increased risk of progression to severe COVID-19 where nirmatrelvir and ritonavir is contraindicated or unsuitable.

BNF Link

Specialist Only
TOCILIZUMAB (Infusion)

Restrictions:

Restricted to use in accordance with current NHSGGC prescribing guidance for COVID-19 (see here for a brief overview of the therapeutic management of each patient group).

BNF Link